Getting Started with NGS for Oncology
Next-Generation Sequencing (NGS). Advancing Precision Oncology.
While it began as a revolutionary research tool a decade ago, NGS is now the method of choice for simultaneous genomic profiling of multiple cancer markers. For hospitals, the advantages of NGS over traditional methods are indisputable in terms of time savings, tissue perservation, and a precision oncology approach to patient care.
NGS In-House Advantages
With NGS testing in-house, you no longer have to give up your samples and rely on outside labs, which can take weeks and potentially lead to high failure rates. With your sample and testing expertise onsite, your multidisciplinary team is always empowered with the information they need to tailor patient treatments for better outcomes.
Ready to get your lab started with NGS?
Get our educational guide and learn:
- Why NGS is such a transformative technology for precision oncology
- How NGS helps improve patient outcomes
- Key oncology applications, and the pros and cons of different sequencing methods
- How surprisingly easy NGS is to implement and operate with its straight-forward, streamlined, highly automated workflow
A Simple Workflow for Any Lab
Now any hospital pathology lab can perform NGS. A highly automated workflow makes it easy for you to get started with your existing staff and infrastructure. Intuitive reporting enables you to deliver the results that capture critical information and links biomarkers to relevant evidence.
NGS tailored to your hospital - today and tomorrow
As your hospital's needs evolve, your flexible NGS platform easily adapts to meet new demands for different types of assays.
One Platform. Multiple Applications.
- Solid tumor profiling from FFPE tissue
- Liquid biopsies
- Hematological malignancy profiling
- Tumor Mutational Burden (TMB) Analysis
Getting started. It's easier than you think.
While the idea of adopting NGS may seem overwhelming, we're confident that you'll find the NGS implementation process much easier than you might think. Our NGS consultants are there every step of the way - from providing analytical assay validation services to creating a CLIA validated offering. You'll be NGS proficient and efficient before you know it.
Webinar: Solving Common Hematopathology Testing Challenges with Next-Generation Sequencing
Learn how NGS can complement your existing laboratory workflows, while providing a powerful new approach for rapidly generating comprehensive molecular data. Hear the speakers’ own perspectives and insights on NGS applications for hemato-oncology, including DNA and RNA profiling using gene panels for myeloid and lymphoid malignancies, as well as immune repertoire sequencing for clonality assessment, MRD detection, and somatic hypermutation analysis of lymphoid samples.
Speakers:
- Dr. Carl Morrison, Roswell Park Comprehensive Cancer Center
- Dr. Sheila Sait, Roswell Park Comprehensive Cancer Center
- Dr. Parth Shah, Dartmouth-Hitchcock
Endeavor to Leave No Patient Behind: NGS Non-Small Cell Lung (NSCL) Biomarker Testing
In this CAP Today webinar, you'll learn how to keep pace with the fast-changing guidelines in precision oncology, test the most challenging samples, and optimize outcomes for as many NSCLC patients as possible.
NGS in NSCLC: Comprehensive Biomarker Testing
See how University Hospital Basel is using NGS testing to inform treatment decisions for lung cancer patients.
Have questions? We look forward to speaking with you about bringing NGS to your hospital's lab.
Trademarks | Terms and Conditions | Privacy Notices
© 2021 Thermo Fisher Scientific Inc. All Rights Reserved.
Select Your Location
United Kingdom
United States